test3

Clinical Trial: NBF-006

Trial Status: Open
Disease Types: Lung, Colorectal, Pancreatic
Trial ID NBF-006
Sponsor ID Nitto BioPharma

A Phase 1/1b Open-Label, Multi-Center, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of Intravenous NBF-006 in Patients with Non-Small Cell Lung, Pancreatic, or Colorectal Cancer Followed by a Dose Expansion Study in Patients with KRAS-Mutated Non-Small Cell Lung Cancer.

Locations

Fairfax Office

Learn More About This Trial
Other Relevant Trials
Trial ID TAK-981-1502
Sponsor ID Takeda Oncology

Phase 1b/2 Study of TAK-981 Plus Pembrolizumab to Evaluate the Safety, Tolerability, and Antitumor Activity of the Combination in Patients With Select Advanced or Metastatic Solid Tumors

1 Location
Trial ID M20-111
Sponsor ID AbbVie

“A Phase 1 first in human study evaluating safety and efficacy of ABBV-637 as either monotherapy or in combination in adult subjects with relapsed and refractory solid tumors”

1 Location